Leukotriene B 4 pathway activation and atherosclerosis in obstructive sleep apnea

Journal of Lipid Research

Volumn 53, Issue 9, 2012, Pages 1944-1951

  Stanke Labesque, Françoise ^a,b,c   Pépin, Jean Louis ^a,b,c   De Jouvencel, Tiphaine ^d   Arnaud, Claire ^a   Baguet, Jean Philippe ^b,c   Petri, Marcelo H ^e   Tamisier, Renaud ^a,b,c   Jourdil, Jean François ^c   Lévy, Patrick ^a,b,c   Bäck, Magnus ^d,e,f  

^a University Grenoble Alpes   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

^d INSERM   (France)

^e KAROLINSKA INSTITUTE   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arachidonic acid; Eicosanoids; Granulocytes; Intermittent hypoxia; Lipoxygenase; Vascular remodeling

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; INTERLEUKIN 6; LEUKOTRIENE B4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; ALOX5AP PROTEIN, HUMAN;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMITTENT HYPOXIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORBIDITY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SLEEP APNEA SYNDROME; BIOSYNTHESIS; BLOOD VESSEL; CASE CONTROL STUDY; CELL HYPOXIA; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEUTROPHIL; PARACRINE SIGNALING; PATHOLOGY; PATHOPHYSIOLOGY; SLEEP DISORDERED BREATHING;

5-LIPOXYGENASE-ACTIVATING PROTEINS; ADULT; AGED; ATHEROSCLEROSIS; BLOOD VESSELS; CASE-CONTROL STUDIES; CELL HYPOXIA; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PARACRINE COMMUNICATION; RNA, MESSENGER; SLEEP APNEA, OBSTRUCTIVE;

EID: 84864829864     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P022814     Document Type: Article

References (26)

1. Baguet, J. P., L. Hammer, P. Levy, H. Pierre, S. Launois, J. M. Mallion, and J. L. Pepin. 2005. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest. 128: 3407-3412. (Pubitemid 41698671)
2. Minoguchi, K., T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito, and M. Adachi. 2005. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 172: 625-630. (Pubitemid 41232975)
3. Drager, L. F., L. A. Bortolotto, M. C. Lorenzi, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho. 2005. Early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 172: 613-618. (Pubitemid 41232973)
4. Lefebvre, B., J. L. Pepin, J. P. Baguet, R. Tamisier, M. Roustit, K. Riedweg, G. Bessard, P. Levy, and F. Stanke-Labesque. 2008. Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Eur. Respir. J. 32: 113-120.
5. Stanke-Labesque, F., M. Bäck, B. Lefebvre, R. Tamisier, J. P. Baguet, N. Arnol, P. Levy, and J. L. Pepin. 2009. Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. J Allergy Clin Immunol 124: 364-370.
6. Goldbart, A. D., J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal. 2006. Inflammatory Mediators in Exhaled Breath Condensate of Children With Obstructive Sleep Apnea Syndrome. Chest. 130: 143-148. (Pubitemid 44116852)
7. Kaditis, A. G., E. Alexopoulos, K. Chaidas, G. Ntamagka, A. Karathanasi, I. Tsilioni, T. S. Kiropoulos, E. Zintzaras, and K. Gourgoulianis. 2009. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest. 135: 1496-1501.
8. Bäck, M., and G. K. Hansson. 2006. Leukotriene receptors in atherosclerosis. Ann. Med. 38: 493-502. (Pubitemid 44764437)
9. Bäck, M. 2009. Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc. Drugs Ther. 23: 41-48.
10. Rouzer, C. A., and S. Kargman. 1988. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263: 10980-10988.
11. Dixon, R. A., R. E. Diehl, E. Opas, E. Rands, P. J. Vickers, J. F. Evans, J. W. Gillard, and D. K. Miller. 1990. Requirement of a 5-lipoxygenase- activating protein for leukotriene synthesis. Nature. 343: 282-284.
12. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237: 1171-1176. (Pubitemid 17131222)
13. Hlawaty, H., M. P. Jacob, L. Louedec, D. Letourneur, C. Brink, J. B. Michel, L. Feldman, and M. Bäck. 2009. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis. Arterioscler. Thromb. Vasc. Biol. 29: 518-524.
14. Leclercq, A., X. Houard, M. Philippe, V. Ollivier, U. Sebbag, O. Meilhac, and J. B. Michel. 2007. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J. Leukoc. Biol. 82: 1420-1429. (Pubitemid 350276953)
15. Helgadottir, A., A. Manolescu, G. Thorleifsson, S. Gretarsdottir, H. Jonsdottir, U. Thorsteinsdottir, N. J. Samani, G. Gudmundsson, S. F. Grant, G. Thorgeirsson, et al. 2004. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36: 233-239. (Pubitemid 38282747)
16. Li, R. C., B. Haribabu, S. P. Mathis, J. Kim, and D. Gozal. 2011. Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis. Am. J. Respir. Crit. Care Med. 184: 124-131.
17. Hosselet, J., I. Ayappa, R. G. Norman, A. C. Krieger, and D. M. Rapoport. 2001. Classification of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 163: 398-405. (Pubitemid 32158519)
18. Bäck, M., A. Sultan, O. Ovchinnikova, and G. K. Hansson. 2007. 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue infl ammation. Circ. Res. 100: 946-949. (Pubitemid 46598919)
19. Dejouvencel, T., D. Feron, P. Rossignol, M. Sapoval, C. Kauffmann, J. M. Piot, J. B. Michel, I. Fruitier-Arnaudin, and O. Meilhac. 2010. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 30: 269-275.
20. Dyugovskaya, L., A. Polyakov, P. Lavie, and L. Lavie. 2008. Delayed neutrophil apoptosis in patients with sleep apnea. Am. J. Respir. Crit. Care Med. 177: 544-554. (Pubitemid 351442194)
21. Havlir, D. V., J. J. Ellner, K. A. Chervenak, and W. H. Boom. 1991. Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 87: 729-733.
22. Borel, J. C., P. Roux-Lombard, R. Tamisier, C. Arnaud, D. Monneret, N. Arnol, J. P. Baguet, P. Levy, and J. L. Pepin. 2009. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS ONE. 4: e6733.
23. 1999. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 22: 667-689.
24. Gonsalves, C. S., and V. K. Kalra. 2010. Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J. Immunol. 184: 3878-3888.
25. Bäck, M., D. X. Bu, R. Branstrom, Y. Sheikine, Z. Q. Yan, and G. K. Hansson. 2005. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. USA. 102: 17501-17506. (Pubitemid 41740895)
26. Tamaki, S., M. Yamauchi, A. Fukuoka, K. Makinodan, N. Koyama, K. Tomoda, M. Yoshikawa, and H. Kimura. 2009. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern. Med. 48: 1255-1262.